"The degree of mean weight reduction seen in SURMOUNT-2 has not been previously achieved in phase 3 trials for obesity or overweight and type 2 diabetes." Participants taking tirzepatide achieved average weight reductions of 13.4% (29.8 lb.) on the lower dose of 10 mg and 15.7% (34.4 lb.) on the higher dose of 15 mg, compared to a placebo group
The peptide therapy guide discusses the appropriate role of peptides within a comprehensive treatment plan
References Cuvellier JC, Lepine A
Pregnant rats were irradiated at E17 to mimic the germline first-hit associated with FCD and after the pups were born, a second-hit was introduced by administering a dose of pentylenetetrazol (PTZ), a GABA receptor antagonist that mediates glutamate excitotoxicity and oxidative stress
Ongoing Support and Adjustments The active membership includes care-team messaging and treatment management
There is no comparable dataset for a four-day interval, which means anyone adopting one is not choosing between two evidence bases they are leaving the evidence base entirely
